Microsoft rises to all-time high after naming former OpenAI CEO Sam Altman as head of its new advanced AI research team. Plus: Shares of Bayer drop about 18% after a clinical trial failure, and a loss in its Roundup case. J.R. Whalen reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices